Full article view2018-07-17T08:45:50+00:00

Improving Payer Engagements Around Smoking Cessation

Three HEDIS measures had been issued by the National Committee for Quality Assurance regarding payer performance on smoking cessation among members.
Despite this, payers had a limited understanding of how smoking cessation quality measures were impacting their overall rating vs other regional health or national benchmarks. This study shows how specific smoking cessation support services were promoted to gain improvement in payer coverage for the products while adhering to PhRMA guidelines.

Get the case study

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.

By continuing to use our website, you agree to our use of cookies to help us give you the best experience, analyze your site usage, and assist in our marketing efforts.
For more information, or to learn how to change your cookies preferences, please click here.